SGC In The Open - the SGC Blog

SGC scientists come from countries all over the world to do drug discovery research at our laboratories in Canada, UK and Brazil.

Watch videos of SGC members talking about SGC science and... [read more]

... [read more]

As 2014 comes to a close we reflect on some of the most interesting epigenetics discoveries of the year.  Epigenetics has emerged as a highly important field in the discovery of new medicines and... [read more]

Yesterday an announcement was made that the... [read more]

Folks been asking me to write some thoughts on various topics – so here goes! 

So I’m now a blogger.

Thought I’d spend the first few blogs introducing myself and the SGC, the... [read more]

At the SGC, we want to help stimulate the discovery of new medicines – yet we explicitly do not file for patents and promptly release information that is customarily... [read more]

In the early months of 2003, I made a trip to England to interview for the SGC Chief Executive position, which was to be based in Oxford.  Prior to the trip, I had agreed with my colleague Cheryl... [read more]

The origins of the Structural Genomics Consortium (SGC) can be traced back to 1999 when Rob Cooke (then at GlaxoWellcome) floated an idea past counterparts in other pharmaceutical companies as to... [read more]

The prevailing view in biomedicine and drug discovery is that we need more “innovation”.  

At the SGC, we (narrowly) interpret “innovation” to mean novel targets and mechanisms because we... [read more]